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Objective: To explore the attitudes of Ghanaian women toward genetic testing for the sickle cell trait and to
investigate key factors that promote or impede the decision to pursue knowledge of the carrier status.
Methods: A survey, administered in person to Ghanaian women, collected demographic information and in-
formation on the participants’ knowledge about their carrier status, their attitudes toward genetic testing,
and their perceptions of the implications of being a carrier. The results for women who had previously under-
gone testing and those who had not were compared. Results: Of 124 participants, 75 had been tested for the
sickle cell trait and 49 had not. Some 53% of the women who had been tested did not know their carrier sta-
tus. Most women agreed that getting a prenatal genetic test was important. However, nontested women
were more likely to lack the financial resources to undergo testing, to think that testing is futile because
sickle cell disease is not curable, and to believe that the outcome of their child's health is determined by
God. Conclusion: The women tended to have favorable attitudes toward genetic testing, but numerous
barriers remained that precluded knowledge of their carrier status or the pursuit of this knowledge.
© 2011 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.1. Introduction
In most African countries, sickle cell disease has yet to be recog-
nized as a major public health concern, mainly because its impact
on mortality is relatively low compared with that of infectious dis-
eases such as HIV/AIDS, malaria, and tuberculosis [1-3]. Recent data
show an increase in morbidity and mortality related to sickle cell dis-
ease, with the highest prevalence in Ghana and Nigeria, where nearly
25% of the population are carriers for the sickle cell trait and 2% of
children are born with sickle cell disease [4,5]. Furthermore, West Af-
ricans have the highest prevalence of the sickle cell trait (1 in 4) com-
pared with other ethnic groups of African origin (e.g. East, North, and
South Africans and African-Caribbeans) [4,5].
Sickle cell disease is inherited as an autosomal recessive trait.
However, unlike people with the disease, those with the sickle cell
trait are generally asymptomatic and can only be identified as carriers
through laboratory testing, or their carrier status becomes obvious
when they have a child with the disease [6]. Thus, autosomal disor-
ders are of particular interest in reproductive planning becauseSchool of Public Health, 3858
, USA. Tel.: +1 734 615 2819;
eration of Gynecology and Obstetrics.many couples may be unaware that they are at risk for having a
child with the disorder.
In its proper context, genetic testing is an unbiased method for
providing pertinent information that may be used to prepare indi-
viduals to manage a genetic disorder and/or to make informed
choices based on relevant knowledge, consistent with the decision-
maker's values [7]. Given the paucity of research exploring African
women's attitudes toward genetic testing for sickle cell disease and
given that voluntary newborn screening for sickle cell disease is
due to be introduced in Ghana on a national level, it is important
and beneficial to the medical community to understand better the
attitudes toward the testing of individuals of childbearing age
because these attitudes may strongly influence future reproductive
decisions [8].
Despite the far-reaching implications of the national sickle cell
newborn-screening program, a large population of trait carriers will
remain unidentified—many of whom are of, or nearing, childbearing
age. Furthermore, although many believe that genetic tests have the
potential to minimize the incidence of disease, the ultimate benefit
of predictive genetic testing is determined, in large part, by the will-
ingness of individuals to undergo testing. Thus, the aim of the present
study was to explore the attitudes of Ghanaian women toward genet-
ic testing for sickle cell trait and the key factors that may promote or
impede decisions to pursue knowledge of carrier status.Published by Elsevier Ireland Ltd. All rights reserved.
Table 1
Characteristics of the participants a.
Parameter Total sample
(n=124)
Tested group
(n=75)
Nontested
group
(n=49)
P value b
Age, y
0–19 1 (0.9) 0 1 (2.3) 0.373
20–40 99 (84.6) 63 (86.3) 36 (81.8)
≥41 17 (14.5) 10 (13.7) 7 (15.9)
Relationship status
Married 101 (82.1) 60 (80.0) 41 (85.4) 0.481
Living with partner 7 (5.7) 6 (8.0) 1 (2.1)
Widowed 2 (1.6) 1 (1.3) 1 (2.1)
Single, divorced 2 (1.6) 2 (2.7) 0 (0.0)
Single, never married 11 (8.9) 6 (8.0) 5 (10.4)
Education
No school 15 (12.2) 3 (4.1) 12 (24.5) b0.001
Completed primary
or middle school
56 (45.5) 31 (41.9) 25 (51.0)
Completed high school
or college
52 (42.3) 40 (54.1) 12 (24.5)
Occupation
Work at home 36 (29.5) 15 (20.5) 21 (42.9) 0.024
Market place trader 26 (21.3) 16 (21.9) 10 (20.4)
Work in an office 40 (32.8) 31 (42.5) 9 (18.4)
Do not work 19 (15.6) 10 (13.7) 9 (18.4)
Other occupation 1 (0.8) 1 (1.4) 0 (0.0)
Religion
Christianity 100 (80.6) 66 (88.0) 34 (69.4) 0.035
Islam 22 (17.7) 8 (10.7) 14 (28.6)
No religion 2 (1.6) 1 (1.3) 1 (2.0)
Ethnicity
Akan 20 (16.8) 12 (16.9) 8 (16.7) b0.001
Ashanti 43 (36.1) 20 (28.2) 23 (47.9)
Fanti 7 (5.9) 6 (8.5) 1 (2.1)
Ewe 12 (10.1) 11 (15.5) 1 (2.1)
Ga-Adangbe 16 (13.4) 14 (19.7) 2 (4.2)
Mole-Dagbani 14 (11.8) 2 (2.8) 12 (25.0)
Guan 4 (3.4) 3 (4.2) 1 (3.4)
Hausa 3 (3) 3 (4.2) 0 (0.0)
Currently pregnant
Yes 37 (29.8) 30 (40.0) 7 (14.3) 0.002 c
No 87 (70.2) 45 (60.0) 42 (85.7)
Recruitment location
Rural health clinic 62 20 (26.7) 42 (85.7) b0.001 c
KBTH Sickle Cell Clinic 62 55 (73.3) 7 (14.3)
Knowledge of sickle cell trait status
Yes 35 (28.9) 34 (47.2) 1 (2.0) b0.001
No 86 (71.1) 38 (52.8) 48 (98.0)
Abbreviations: KBTH, Korle Bu Teaching Hospital.
a Values are given as number (percentage). Numbers may not add up to the total
number of participants because some survey questions were unanswered.
b Pearson χ2 test unless otherwise indicated.
c Fisher exact test.
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The present prospective, cross-sectional study was conducted at
the Korle Bu Teaching Hospital Sickle Cell Clinic at the University of
Ghana in Accra, various regional health clinics within the districts of
Atwima Nwabiagya, Afigya Kwabre, and Sekyere East, and in
Community-Based Health Planning and Services (CHPS) compounds
in Amansie West, Ahafo Ano South, and Tolon-Kumbungu—all in
Ghana. The study sites included rural and metropolitan centers be-
cause health service use among women in rural areas tends to be dif-
ferent from that in metropolitan areas, where income and access to
education and healthcare facilities are greater [9,10]. The study cohort
included Ghanaian women over the age of 18 years who were carriers
or non-carriers of sickle cell trait; the women were recruited from
these locations during June 2009 through February 2010.
Women over 18 years of age who were Ghanaian residents were
asked if they were willing to participate in a research study about ge-
netic testing. Research staff explained that the study involved an
anonymous survey of approximately 20 minutes in length and an-
swered any questions. Prior knowledge of their sickle cell status had
no influence on a woman's eligibility for participation.
To enable the investigation of attitudes and influential factors con-
cerning genetic testing, the survey collected information about the
participants’ knowledge of sickle cell disease, about their cultural
views and personal beliefs, and about sociocultural factors. At the re-
gional health clinics and CHPS compound locations, the survey was
administered by 2 of the authors (L.E. and D.U.); at Korle Bu Teaching
Hospital, clinic staff conducted the survey. The survey was adminis-
tered in English and, if possible, in the participant's native language
with the aid of a translator.
The data were analyzed using SPSS version 18.0 (SPSS, Chicago,
IL, USA). Descriptive data were presented as number (percentage).
The Pearson χ2 test and the Fisher exact test were used to com-
pare the percentages between women who had previously under-
gone genetic testing and those who had not. Pb0.05 was considered
statistically significant.
The study was approved by the Institutional Review Board of the
University of Michigan Medical School, Ann Arbor, MI, USA; the Com-
mittee for Human Research, Publications and Ethics of the Kwame
Nkrumah University of Science and Technology, Komfo Anokye
Teaching Hospital, Kumasi, Ghana; and the Institutional Review
Board of the Noguchi Memorial Institute for Medical Research, Uni-
versity of Ghana, Legon, Ghana.
3. Results
In total, 127 women (age range 16–67 years, mean age 32.7 years)
were recruited into the present study. Of these, 30 (23.6%) reported
being a primary caregiver of a child with sickle cell disease and
99 (76.2%) believed sickle cell diseasewas oneof theworst diseases pos-
sible. In total, 124 women answered the question of whether they had
ever been tested for the sickle cell trait. Based on their responses, the
participants were divided into 2 groups, with the tested group compris-
ing 75 (60.5%) women and the nontested group comprising 49 (39.5%)
women. The characteristics of the 2 groups are described in Table 1.
A significantly greater proportion of women who had been tested
disagreed with the statement “I did not have the money to get test-
ed”, compared with those who had not been tested (76.7% versus
27.1%, Pb0.001; Table 2). Women in the tested group were also
more likely to reject the notion that they did not want to get tested
because the disease is incurable (87.7% versus 61.2%, P=0.005). No
significant differences were detected between the 2 groups in terms
of awareness of the availability of genetic testing, fear of testing be-
cause of a fear of needles, and the time point in relation to pregnancy
at which participants desired to be tested. Also, nearly all (90.3%) par-
ticipants believed pregnant women should undergo testing.Significantly more women in the nontested group (70.8% versus
28.4%, Pb0.001) stated that they would feel less healthy if they
knew that they carried the sickle cell gene (Table 3). Women who
had not been tested also tended to be more concerned that they
might feel singled out if they tested positive, although this difference
was not statistically significant (40% versus 7%, P=0.065). The pro-
portion of those agreeing with the notion that knowledge of their
sickle cell status would help them to make important life decisions
was significantly higher in the tested group than in the nontested
group (88.6% versus 69.4%, P=0.005). The tested group also com-
prised a greater proportion of women who agreed that knowledge
of the sickle cell status is valuable (90.7% versus 79.6%, P=0.109).
With regard to knowledge about transmission of the genetic trait
(Table 3), women who had not been tested were significantly more
likely to believe that it was in God's hands whether their child had
sickle cell disease (69.4% versus 36.0%, P=0.001), and more likely
to say that they would leave it to God to decide what will happen to
their child (64.6% versus 33.8%, P=0.004).
Table 3
Perceived implications of genetic testing a.
Survey item Total sample
(n=124)
Tested group
(n=75)
Nontested group
(n=49)
P value b
Knowing that I carry the sickle cell gene would cause me to feel less healthy than
other people
Agree 55 (45.1) 21 (28.4) 34 (70.8) b0.001
Neutral 7 (5.7) 5 (6.8) 2 (4.2)
Disagree 60 (49.2) 48 (64.9) 12 (25.0)
If anyone found out that I carried the sickle cell gene it would keep me from getting
married
Agree 58 (50.4) 31 (46.3) 27 (56.3) 0.313
Neutral 5 (4.3) 2 (3.0) 3 (6.3)
Disagree 52 (45.2) 34 (50.7) 18 (37.5)
When I found out that I carried the sickle cell gene, it made me feel singled out
Agree 5 (10.4) 3 (7.0) 2 (40.0) 0.065
Neutral 4 (8.3) 4 (9.3) 0 (0.0)
Disagree 39 (60.0) 36 (83.7) 3 (60.0)
Knowing that I carry the sickle cell gene has helped me make important life
decisions
Agree 96 (80.7) 62 (88.6) 34 (69.4) 0.016
Neutral 3 (2.5) 2 (2.9) 1 (2.0)
Disagree 20 (16.8) 6 (8.6) 14 (28.6)
Knowing whether I have the sickle cell gene is valuable information
Agree 107 (86.3) 68 (90.7) 39 (79.6) 0.109 c
Neutral 0 (0.0) 0 (0.0) 0 (0.0)
Disagree 17 (13.7) 7 (9.3) 10 (20.4)
It is in God's hands if my child has sickle cell disease
Agree 61 (49.2) 27 (36.0) 34 (69.4) 0.001
Neutral 4 (3.2) 4 (5.3) 0 (0.0)
Disagree 59 (47.6) 44 (58.7) 15 (30.6)
I will leave it to God to decide what will happen to my child
Agree 56 (45.9) 25 (33.8) 31 (64.6) 0.004
Neutral 5 (4.1) 4 (5.4) 1 (2.1)
Disagree 61 (50.0) 45 (60.8) 16 (33.3)
It is important to my family that I have children
Agree 116 (94.3) 69 (93.2) 47 (95.9) 0.702 c
Neutral 0 (0.0) 0 (0.0) 0 (0.0)
Disagree 7 (5.7) 5 (6.8) 2 (4.1)
I would be incomplete as a woman if I did not have a child
Agree 88 (72.7) 53 (73.6) 35 (71.4) 0.837 c
Neutral 0 (0.0) 0 (0.0) 0 (0.0)
Disagree 33 (27.3) 19 (26.4) 14 (28.6)
Getting tested would not make a difference to me having my baby
Agree 76 (61.8) 47 (63.5) 29 (59.2) 0.845
Neutral 8 (6.5) 5 (6.8) 3 (6.1)
Disagree 39 (31.7) 22 (29.7) 17 (34.7)
a Values are given as number (percentage). Numbers may not add up to the total
number of participants because some survey questions were unanswered.
b Pearson χ2 test unless otherwise indicated.
c Fisher exact test.
Table 2
Attitudes toward genetic testing for the sickle cell trait a.
Survey item Total
sample
(n=124)
Tested
group
(n=75)
Nontested
group
(n=49)
P value b
I did not know I could get tested 0.218
Agree 45 (36.3) 23 (30.7) 22 (44.9)
Neutral 9 (7.3) 5 (6.7) 4 (8.2)
Disagree 70 (56.5) 47 (62.7) 23 (46.9)
I did not have the money to get tested b0.001
Agree 50 (41.3) 17 (23.3) 33 (68.8)
Neutral 2 (1.7) 0 (0.0) 2 (4.2)
Disagree 69 (57.0) 56 (76.7) 13 (27.1)
I did not want to get tested because sickle cell can't be cured
anyway
0.005
Agree 24 (22.6) 7 (12.3) 17 (34.7)
Neutral 2 (1.9) 0 (0.0) 2 (4.1)
Disagree 80 (75.5) 50 (87.7) 30 (61.2)
I was afraid to get tested (afraid of needles) 0.385
Agree 23 (18.5) 11 (14.7) 12 (24.5)
Neutral 3 (2.4) 2 (2.7) 1 (2.0)
Disagree 98 (79.) 62 (82.7) 36 (73.5)
I wanted to be tested at some point, but not while I was pregnant 0.219
Agree 73 (60.8) 46 (64.8) 27 (55.1)
Neutral 2 (1.7) 2 (2.8) 0 (0.0)
Disagree 45 (37.5) 23 (32.4) 22 (44.9)
I wanted to be tested immediately when I found out I was
pregnant
0.078
Agree 59 (49.6) 30 (42.3) 29 (60.4)
Neutral 3 (2.5) 3 (4.2) 0 (0.0)
Disagree 57 (47.9) 38 (53.5) 19 (39.6)
I think pregnant women should get a prenatal genetic test 0.931
Agree 112 (90.3) 68 (90.7) 44 (89.8)
Neutral 3 (2.4) 2 (2.7) 1 (2.0)
Disagree 9 (7.3) 5 (6.7) 4 (8.2)
a Values are given as number (percentage). Numbers may not add up to the total
number of participants because some survey questions were unanswered.
b Pearson χ2 test.
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was important to their families that they have children (Table 3),
and more than half (61.8%) said that getting tested would not make
any difference as to whether they would have their child.
Table 4 illustrates that, although participants did not have an accu-
rate understanding of the disease etiology (only 18.3% answered the
first question correctly and 6.5% answered the second question cor-
rectly), more participants understood the etiology when only 1 par-
ent is a carrier than when both parents are carriers of sickle cell
trait. However, participants did have a moderate understanding of
how being a carrier affects a person.
4. Discussion
The present study highlights the complexities of deciding whether
to undergo genetic testing and acknowledges that these decisions can
be influenced both by personal factors (values and belief systems)
and by factors originating from larger social-structural forces (social
hierarchies of wealth and power). The findings of the present study
indicate that women in Ghana may recognize the benefits of genetic
testing, but that structural barriers may preclude them from acting
in accordance with their beliefs. As with previous studies, various
sociodemographic characteristics were associated with the decision
to undergo testing for the sickle cell trait [11,12]. More specifically,
the present study identified low financial resources and a low level
of education as potential barriers to genetic testing.
Geller and Holtzman [13] suggested that “those at the lower end
of the socioeconomic spectrum, for whom genetic testing may be a
low priority, are thought to be those least able to afford the conse-
quences of not knowing about genetic diseases in their families”. A
lower level of education generally indicates a lack of awareness that
testing is available, but in the present study, those with a lowerlevel of education were not only less likely to undergo testing; they
were also less likely to have an accurate knowledge of the implica-
tions of being a carrier of the sickle cell trait.
One of the key findings of the present study is that women
recruited from the sickle cell clinic were more likely to have under-
gone testing than people recruited from a rural health clinic. This find-
ing may reflect the expertise of providers who specialize in this area
and who, by training and exposure, are more knowledgeable about
the clinical sequelae of sickle cell disease and the availability and loca-
tions for testing, and who are generally more confident in providing
quality genetic counseling. Additionally, the present results indicate
that although a large portion of participants reported having been
tested, only 47% of those women knew whether they actually carried
the sickle cell trait. This strongly suggests a lack of understanding of
the test results—an area that is apparently in much need of improve-
ment. Gordon and colleagues [14] suggest that the way in which ge-
netic risk is communicated by healthcare providers and interpreted
by those at risk too often results in a less than ideal understanding of
the information provided, and that decreased retention of the infor-
mation over time limits the ability to make an informed decision.
With illnesses such as sickle cell disease, the ability of healthcare
Table 4
Knowledge about the reproductive and clinical implications of being a carrier of the sickle cell trait a.
Survey item Total sample (n=124) Tested group (n=75) Nontested group (n=49)
If only 1 parent is a carrier of the sickle cell trait and the other is not, what are the chances that the child will have sickle cell disease
All children will have sickle cell disease 8 (6.7) 5 (6.9) 3 (6.3)
None of the children will have sickle cell disease 22 (18.3) 15 (20.8) 7 (14.6)
One in 2 (50%) children will have sickle cell disease 26 (21.7) 15 (20.8) 11 (22.9)
One in 4 (25%) children will have sickle cell disease 24 (20.0) 17 (23.6) 7 (14.6)
One in 10 (10%) children will have sickle cell disease 6 (5.0) 4 (5.6) 2 (4.2)
Don't know 34 (28.3) 16 (22.2) 18 (37.5)
If both parents are carriers of the sickle cell trait, what are the chances that the child will have sickle cell disease
All children will have sickle cell disease 38 (38.9) 20 (27.0) 18 (36.7)
None of the children will have sickle cell disease 1 (0.8) 1 (1.4) 0
One in 2 (50%) children will have sickle cell disease 41 (33.3) 33 (44.6) 8 (16.3)
One in 4 (25%) children will have sickle cell disease 8 (6.5) 6 (8.1) 2 (4.1)
One in 10 (10%) children will have sickle cell disease 4 (3.3) 1 (1.4) 3 (6.1)
Don't know 31 (25.2) 13 (17.6) 18 (36.7)
How does the sickle cell trait usually affect a person?
They usually go on to develop sickle cell disease 11 (9.3) 8 (11.4) 3 (6.3)
They sometimes have no symptoms and many do not know that they are carriers 34 (28.8) 26 (37.1) 8 (16.7)
They have the same symptoms as people with sickle cell disease but do not get ill as often 47 (39.8) 26 (37.1) 21 (43.8)
They start off with sickle cell disease but get better as they get older 2 (1.7) 0 (0.0) 2 (2.9)
Don't know 23 (19.5) 8 (11.4) 15 (31.3)
a Values are given as number (percentage). Numbers may not add up to the total number of participants because some survey questions were unanswered.
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found influence on whether the encounter with a patient supports
or discourages decisions and subsequent actions [15]. Unfortunately,
most Ghanaian initiatives to educate patients about sickle cell disease
are limited to sickle cell centers in Accra and Kumasi [3].
Finally, existing cultural mores—developed through religious
membership, tribe affiliation, and regional influences—greatly influ-
ence women's attitudes toward motherhood and family size [16,17].
In Ghana, women have historically occupied a lower social status
than men and they often view children and grandchildren as a source
of pride and a means of improving their status [18,19]. The findings of
the present study indicate that women in Ghana place a high value on
fulfilling cultural and familial expectations about childbearing. It
would therefore be prudent for community health programs to take
the significance of motherhood into consideration when developing
educational programs of any kind.
Furthermore, the group who were not tested included a higher
proportion of womenwho believed that God determines the outcome
of their child's health, who did not undergo testing because sickle cell
is incurable, and who stated that they would proceed with childbirth
regardless of a diagnosis of sickle cell disease. These findings indicate
that sufficient attention should be given to effective disease manage-
ment rather than prevention. Efforts should be made to ensure that
parents are able to recognize the symptoms of sickle cell disease
and to prepare them to manage this disease in a variety of social set-
tings (e.g. rural, urban). Also, more women in the nontested group
than in the tested group reported that knowledge that they were car-
riers wouldmake them feel less healthy and singled out. Therefore, an
effort should be made to decrease the stigma associated with being a
carrier, which also may discourage women from pursuing a test for
the sickle cell trait. For potential genetic testing programs in Ghana
to be successful, the use of culturally acceptable approaches must be
taken into consideration [3].
Several limitations of the present study should be noted. Given
that the survey was administered in English, participants could have
misunderstood the questions even if an interpreter was present.
Also, given the limited number of study sites, the participants may
not be a representative sample of Ghanaian women.
Genetic testing can potentially be an effective strategy for identi-
fying sickle cell trait carriers and serve as a tool for informed repro-
ductive decision-making [3,20]. However, for this method to be
effective, it is important to understand the ways in which structuralforces, social norms, and traditional beliefs influence a woman's abil-
ity to make such decisions and act upon them [16]. Additionally,
while women may decide to undergo testing, they may continue to
lack a clear understanding of the underlying concepts and conse-
quences associated with carrying the sickle cell trait. Proximity to re-
gional medical centers may play a role in community exposure to
information about sickle cell disease and carrier testing. Further re-
search is needed to explore the acceptability of genetic testing in re-
lation to family planning and the effectiveness of existing
educational materials used outside the 2 sickle cell centers (Accra
and Kumasi) in order to improve informed reproductive decision-
making in Ghana.
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